4Bio Ventures
Venture capitalLondon
Fund manager profile
4Bio Ventures is a venture fund manager based in London. SEC filings show 1 venture fund on record, most recently 4Bio Ventures III LP ($200M offering) filed September 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Deep Tech ×1Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 12 dated
Novaptix develops non-viral gene writing technology intended to support the development and scaling of gene therapies.
BiotechDeep TechMedical DevicesBerkeley, US
Kevin Holden(Executive Officer, Director, Promoter)
BoardAudrey Kozlov(Director)Daniel Dever(Director)
Board seatDmitry Kuzmin· per SEC Form D · $7.5M raise · filed Mar 2025
Restoring vision through optogenetics.
BiotechSan Francisco, US
Paul Bresge(Executive Officer, Director)Sean Ainsworth(Executive Officer, Director)
BoardTiba Aynechi(Director)inRaymond Camahort(Director)Hannah Chang(Director)
Board seatDmitry Kuzmin· per SEC Form D · $100M raise · filed May 2023
Co-investorsMRL Ventures FundNorwest Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is 4Bio Ventures located?
- 4Bio Ventures is headquartered in London.